Effect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group study

dc.contributor.authorGuvenal, Tevfik
dc.contributor.authorDursun, Polat
dc.contributor.authorHasdemir, Pinar S.
dc.contributor.authorHanhan, Merih
dc.contributor.authorGuven, Suleyman
dc.contributor.authorYetimalar, Hakan
dc.contributor.authorAyhan, Ali
dc.date.accessioned2026-08-12T17:48:05Z
dc.date.issued2013
dc.departmentFırat Üniversitesi
dc.description.abstractObjective. The objectives of this study were to examine demographic and clinicopathologic characteristics and to determine the effects of primary surgery, surgical staging and the extensiveness of staging. Methods. In a retrospective Turkish multicenter study, 539 patients, from 14 institutions, with borderline ovarian tumors were investigated. Some of the demographic, clinical and surgical characteristics of the cases were evaluated. The effects of type of surgery, surgical staging; complete or incomplete staging on survival rates were calculated by using Kaplan-Meier method. Results. The median age at diagnosis was 40 years (range 15-84) and 71.1% of patients were premenopausal. The most common histologic types were serous and mucinous. Majority of the staged cases were in Stage IA (735%). 242 patients underwent conservative surgery. Recurrence rates were significantly higher in conservative surgery group (8.3% vs. 3%). Of all patients in this study, 294 (545%) have undergone surgical staging procedures. Of the patients who underwent surgical staging, 228 (77.6%) had comprehensive staging including lymphadenectomy. Appendectomy was performed on 204 (37.8%) of the patients. The median follow-up time was 36 months (range 1-120 months). Five-year survival rate was 100% and median survival time was 120 months. Surgical staging, lymph node sampling or dissection and appendectomy didn't cause any difference on survival. Conclusion. Comprehensive surgical staging, lymph node sampling or dissection and appendectomy are not beneficial in borderline ovarian tumors surgical management. (C) 2013 Elsevier Inc. All rights reserved.
dc.identifier.doi10.1016/j.ygyno.2013.08.038
dc.identifier.endpage550
dc.identifier.issn0090-8258
dc.identifier.issn1095-6859
dc.identifier.issue3
dc.identifier.orcid0000-0002-0754-4655
dc.identifier.orcid0000-0001-5139-364X
dc.identifier.orcid0000-0002-4330-0228
dc.identifier.orcid0000-0002-2163-6329
dc.identifier.orcid0000-0003-0197-6622
dc.identifier.orcid0000-0003-4832-4525
dc.identifier.pmid24016409
dc.identifier.scopus2-s2.0-84888291135
dc.identifier.scopusqualityQ1
dc.identifier.startpage546
dc.identifier.urihttps://doi.org/10.1016/j.ygyno.2013.08.038
dc.identifier.urihttps://hdl.handle.net/11508/61288
dc.identifier.volume131
dc.identifier.wosWOS:000327923400010
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAcademic Press Inc Elsevier Science
dc.relation.ispartofGynecologic Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectBorderline
dc.subjectOvarian tumor
dc.subjectLymphadenectomy
dc.subjectAppendectomy
dc.subjectSurgical staging
dc.titleEffect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group study
dc.typeArticle

Dosyalar